SUMMARY -Myasthenia gravis is associated in 10 to 15 percent of patients with thymic tumors, rarely with aplastic anemia. We report a 45-year-old male diagnosed with myasthenia gravis associated with thymoma. We started treatment with pyridostigmine. After thymectomy, the patient received 30 irradiation sessions. In the postoperative course, he had mild worsening of myasthenia gravis, which improved with prednisone. Five months later, he developed severe aplastic anemia. He was dependent on blood supplement. After allogeneic transplantation of bone marrow, he improved but later he developed graft versus host disease. Myasthenia gravis was under good control with 480 mg of pyridostigmine per day.
The rupture of aneurysm and subarachnoidal hemorrhage (SAH) is complex intracranial condition. Often accompanied with dramatic clinical presentation, necessity for emergency diagnostic treatment and various complications. To make sure that proper diagnostic approach is provided for this patients
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.